Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cagatay Taskiran

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
BMC Cancer|February 4, 2026
Homologous recombination deficiency in newly diagnosed advanced ovarian cancer across nine Middle East countries: prevalence, real-world testing pathways, and treatment implicationsEmad Shash, Mehemet Ali Vardar, Cagatay Taskiran, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Non-invasive mediastinal lymph node metastasis of serous borderline ovarian tumorMuhterem Melis Canturk, Burak Giray, Dogan Vatansever, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 4, 2024
Non-invasive mediastinal lymph node metastasis of serous borderline ovarian tumorMuhterem Melis Canturk, Burak Giray, Dogan Vatansever, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 28, 2022
Perspectives of Gynecologic Oncologists on Minimally Invasive Surgery During COVID-19 Pandemic: A Turkish Society of Minimally Invasive Gynecologic Oncology (MIJOD) SurveyNasuh Utku Dogan, Esra Bilir, Salih Taskin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 24, 2024
ESGE/ESGO/SERGS consensus statement on surgical steps in minimally invasive surgery in gynecologic oncology: transperitoneal and extraperitioneal approach for paraaortic lymphadenectomyRamon Rovira, Liliana Mereu, François Planchamp, et al.
American Journal of Obstetrics and Gynecology|January 4, 2006
The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experienceAli Ayhan, Murat Gultekin, Cagatay Taskiran, et al.
Biological Trace Element Research|March 26, 2014
Zinc and homocysteine levels in polycystic ovarian syndrome patients with insulin resistanceIsmail Guler, Ozdemir Himmetoglu, Ahmet Turp, et al.
Journal of Pediatric Hematology/Oncology|May 15, 2013
Clear cell adenocarcinoma of the uterine cervix: a case report and review of the literatureMeltem Baykara, Mustafa Benekli, Ozlem Erdem, et al.
Scientific Reports|June 13, 2024
Patients with gynecological malignancies are similar to other IVF patients without cancer for clinical and molecular reproductive parameters and DNA damage response patternYashar Esmaeilian, Sevgi Yusufoglu, Ece İltumur, et al.
Human Reproduction (Oxford, England)|November 11, 2022
IVF characteristics and the molecular luteal features of random start IVF cycles are not different from conventional cycles in cancer patientsYashar Esmaeilian, Francesko Hela, Gamze Bildik, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
BMC Cancer|February 4, 2026
Homologous recombination deficiency in newly diagnosed advanced ovarian cancer across nine Middle East countries: prevalence, real-world testing pathways, and treatment implicationsEmad Shash, Mehemet Ali Vardar, Cagatay Taskiran, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Non-invasive mediastinal lymph node metastasis of serous borderline ovarian tumorMuhterem Melis Canturk, Burak Giray, Dogan Vatansever, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 4, 2024
Non-invasive mediastinal lymph node metastasis of serous borderline ovarian tumorMuhterem Melis Canturk, Burak Giray, Dogan Vatansever, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 28, 2022
Perspectives of Gynecologic Oncologists on Minimally Invasive Surgery During COVID-19 Pandemic: A Turkish Society of Minimally Invasive Gynecologic Oncology (MIJOD) SurveyNasuh Utku Dogan, Esra Bilir, Salih Taskin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 24, 2024
ESGE/ESGO/SERGS consensus statement on surgical steps in minimally invasive surgery in gynecologic oncology: transperitoneal and extraperitioneal approach for paraaortic lymphadenectomyRamon Rovira, Liliana Mereu, François Planchamp, et al.
American Journal of Obstetrics and Gynecology|January 4, 2006
The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experienceAli Ayhan, Murat Gultekin, Cagatay Taskiran, et al.
Biological Trace Element Research|March 26, 2014
Zinc and homocysteine levels in polycystic ovarian syndrome patients with insulin resistanceIsmail Guler, Ozdemir Himmetoglu, Ahmet Turp, et al.
Journal of Pediatric Hematology/Oncology|May 15, 2013
Clear cell adenocarcinoma of the uterine cervix: a case report and review of the literatureMeltem Baykara, Mustafa Benekli, Ozlem Erdem, et al.
Scientific Reports|June 13, 2024
Patients with gynecological malignancies are similar to other IVF patients without cancer for clinical and molecular reproductive parameters and DNA damage response patternYashar Esmaeilian, Sevgi Yusufoglu, Ece İltumur, et al.
Human Reproduction (Oxford, England)|November 11, 2022
IVF characteristics and the molecular luteal features of random start IVF cycles are not different from conventional cycles in cancer patientsYashar Esmaeilian, Francesko Hela, Gamze Bildik, et al.
Pageof 11